| Phase 1 | 2 | |
| Phase 1/2 | 2 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05549297 | Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma… | Advanced Melanoma | Recruiting | 2026-02-25 |
| NCT06112314 | IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma… | Advanced Melanoma | Recruiting | 2026-02-25 |
| Phase 1/2 | ||||
| NCT06840119 | Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers | Cancer | Recruiting | 2026-01-28 |
| NCT04262466 | Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint… | Select Advanced Solid Tumors | Active, Not Recruiting | 2026-03-06 |
| Phase 1 | ||||
| NCT07156136 | Study of IMC-P115C in Advanced PRAME-Positive Cancers | PRAME Positive | Recruiting | 2026-02-25 |
| NCT07493122 | Study of IMC-S118AI in Type 1 Diabetes | Type 1 Diabetes | Not Yet Recruiting | 2026-03-25 |
Melanoma (2) · Diabetes (1) · Type 1 Diabetes (1)